NUC Price sensitive 27 Aug 2026, 4:40 PM

Appendix 4E and FY26 Full Year Statutory Accounts

Nuchev Ltd

Nuchev Ltd FY26 Financial Results

Key points

  • Revenue increased by 12.0% to $25.684 million
  • Net loss after tax rose to $7.388 million
  • No dividends declared for FY26
  • Strategic focus on improving revenue conversion and profitability
  • Expansion into new markets and product categories

Full summary

Nuchev Ltd reported a 12% increase in revenue to $25.684 million for the financial year ended 30 June 2026. Despite this growth, the company's net loss after tax increased significantly to $7.388 million, up from $3.823 million the previous year. The company did not declare any dividends for the financial year. The revenue growth was driven by the continued performance of domestic Oli6® retail, contributions from the Practitioner business, and the growing contribution from Brauer and the broader distribution activities. However, international revenue remained inconsistent due to product registration, import documentation, and launch timing in Vietnam. The company also recorded an adjusted EBITDA loss of $4.556 million, compared with a loss of $3.343 million in the prior year. The loss was attributed to the lower gross margin and the continued cost of supporting the broader product portfolio, distribution capability, new product activity, and market development.

Guidance

Revenue of $25.684M for FY26, net loss after tax of $7.388M

Outlook

Nuchev Ltd is focusing on improving revenue conversion, profitability, and strategic initiatives to build on its broader operating platform across various sectors.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in